Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

KCP-256: A novel glucose concentration-dependent potentiator of insulin secretion

Jan. 10, 2006

Treatment completed in pivotal TRIUMPH study of eculizumab in PNH

Jan. 10, 2006

Recent patents describe possible new agents for diabetes

Jan. 9, 2006

Climara Pro approved for prevention of postmenopausal osteoporosis

Jan. 9, 2006

Northfield to receive defense appropriation for PolyHeme development

Jan. 9, 2006

Neose Technologies cleared to study NE-180 in phase I trial

Jan. 9, 2006

Preclinical and clinical erythropoietic activity of CNTO-528

Jan. 5, 2006

sanofi-aventis prepares and tests new histamine H3 receptor antagonists

Jan. 5, 2006

U.S. Navy to receive defense appropriation for Hemopure R&D

Jan. 5, 2006

U.S. launch for Increlex

Jan. 4, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...